Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases

1. Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M, et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 2004; 58: 1496–505. doi: 10.1016/j.ijrobp.2003.09.024 RickeJ WustP StohlmannA BeckA ChoCH PechM CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique Int J Radiat Oncol Biol Phys 2004 58 1496 505 10.1016/j.ijrobp.2003.09.024 Open DOISearch in Google Scholar

2. Ricke J, Wust P, Wieners G, Beck A, Cho CH, Seidensticker M, et al. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation. J Vasc Interv Radiol 2004; 15: 1279–86. doi: 10.1097/01.Rvi.0000141343.43441.06 RickeJ WustP WienersG BeckA ChoCH SeidenstickerM Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation J Vasc Interv Radiol 2004 15 1279 86 10.1097/01.Rvi.0000141343.43441.06 Open DOISearch in Google Scholar

3. Seidensticker M, Wust P, Rühl R, Mohnike K, Pech M, Wieners G, et al. Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases. Radiat Oncol 2010; 5: 24. doi: 10.1186/1748-717x-5-24 SeidenstickerM WustP RühlR MohnikeK PechM WienersG Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases Radiat Oncol 2010 5 24 10.1186/1748-717x-5-24 Open DOISearch in Google Scholar

4. Ricke J, Mohnike K, Pech M, Seidensticker M, Rühl R, Wieners G, et al. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2010; 78: 479–85. doi: 10.1016/j.ijrobp.2009.09.026 RickeJ MohnikeK PechM SeidenstickerM RühlR WienersG Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy Int J Radiat Oncol Biol Phys 2010 78 479 85 10.1016/j.ijrobp.2009.09.026 Open DOISearch in Google Scholar

5. Wybranski C, Zeile M, Löwenthal D, Fischbach F, Pech M, Röhl FW, et al. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases. Radiat Oncol 2011; 6: 43. doi: 10.1186/1748-717x-6-43 WybranskiC ZeileM LöwenthalD FischbachF PechM RöhlFW Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases Radiat Oncol 2011 6 43 10.1186/1748-717x-6-43 Open DOISearch in Google Scholar

6. Bretschneider T, Ricke J, Gebauer B, Streitparth F. Image-guided high-dose-rate brachytherapy of malignancies in various inner organs − technique, indications, and perspectives. J Contemp Brachytherapy 2016; 8: 251–61. doi: 10.5114/jcb.2016.61068 BretschneiderT RickeJ GebauerB StreitparthF Image-guided high-dose-rate brachytherapy of malignancies in various inner organs − technique, indications, and perspectives J Contemp Brachytherapy 2016 8 251 61 10.5114/jcb.2016.61068 Open DOISearch in Google Scholar

7. Omari J, Drewes R, Orthmer M, Hass P, Pech M, Powerski M. Treatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, inter-stitial brachytherapy as second-line or salvage therapy. Diagn IntervRradiol 2019; 25: 360–7. doi: 10.5152/dir.2019.18390 OmariJ DrewesR OrthmerM HassP PechM PowerskiM Treatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, inter-stitial brachytherapy as second-line or salvage therapy Diagn IntervRradiol 2019 25 360 7 10.5152/dir.2019.18390 Open DOISearch in Google Scholar

8. Chow DH, Sinn LH, Ng KK, Lam CM, Yuen J, Fan ST, et al. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study. J Surg Oncol 2006; 94: 565–71. doi: 10.1002/jso.20674 ChowDH SinnLH NgKK LamCM YuenJ FanST Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study J Surg Oncol 2006 94 565 71 10.1002/jso.20674 Open DOISearch in Google Scholar

9. Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 1992; 159: 591–9. doi: 10.2214/ajr.159.3.1503032 Le BihanD TurnerR DouekP PatronasN Diffusion MR imaging: clinical applications AJR Am J Roentgenol 1992 159 591 9 10.2214/ajr.159.3.1503032 Open DOISearch in Google Scholar

10. Dudeck O, Zeile M, Wybranski C, Schulmeister A, Fischbach F, Pech M, et al. Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy. Eur Radiol 2010; 20: 2699–706. doi: 10.1007/s00330-010-1846-z DudeckO ZeileM WybranskiC SchulmeisterA FischbachF PechM Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy Eur Radiol 2010 20 2699 706 10.1007/s00330-010-1846-z Open DOISearch in Google Scholar

11. Welsh JS, Kennedy AS, Thomadsen B. Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2006; 66(2 Suppl): S62–73. doi: 10.1016/j.ijrobp.2005.09.011 WelshJS KennedyAS ThomadsenB Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma Int J Radiat Oncol Biol Phys 2006 66 2 Suppl S62 73 10.1016/j.ijrobp.2005.09.011 Open DOISearch in Google Scholar

12. Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30: 52–60. doi: 10.1055/s-0030-1247132 LencioniR LlovetJM Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 2010 30 52 60 10.1055/s-0030-1247132 Open DOISearch in Google Scholar

13. Kim MN, Kim BK, Han KH, Kim SU. Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment. Expert Rev Gastroenterol Hepatol 2015; 9: 335–48. doi: 10.1586/17474124.2015.959929 KimMN KimBK HanKH KimSU Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment Expert Rev Gastroenterol Hepatol 2015 9 335 48 10.1586/17474124.2015.959929 Open DOISearch in Google Scholar

14. Vouche M, Kulik L, Atassi R, Memon K, Hickey R, Ganger D, et al. Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: imaging analysis from a prospective randomized trial of Y90 ± Sorafenib. Hepatology 2013; 58: 1655–66. doi: 10.1002/hep.26487 VoucheM KulikL AtassiR MemonK HickeyR GangerD Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: imaging analysis from a prospective randomized trial of Y90 ± Sorafenib Hepatology 2013 58 1655 66 10.1002/hep.26487 Open DOISearch in Google Scholar

15. Vossen JA, Buijs M, Kamel IR. Assessment of tumor response on MR imaging after locoregional therapy. Tech Vasc Interv Radiol 2006; 9: 125–32. doi: 10.1053/j.tvir.2007.02.004 VossenJA BuijsM KamelIR Assessment of tumor response on MR imaging after locoregional therapy Tech Vasc Interv Radiol 2006 9 125 32 10.1053/j.tvir.2007.02.004 Open DOISearch in Google Scholar

16. Ludwig JM, Camacho JC, Kokabi N, Xing M, Kim HS. The role of diffusion-weighted imaging (DWI) in Locoregional therapy outcome prediction and response assessment for hepatocellular carcinoma (HCC): the new era of functional imaging biomarkers. Diagnostics 2015; 5: 546–63. doi: 10.3390/diagnostics5040546 LudwigJM CamachoJC KokabiN XingM KimHS The role of diffusion-weighted imaging (DWI) in Locoregional therapy outcome prediction and response assessment for hepatocellular carcinoma (HCC): the new era of functional imaging biomarkers Diagnostics 2015 5 546 63 10.3390/diagnostics5040546 Open DOISearch in Google Scholar

17. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228–47. doi: 10.1016/j.ejca.2008.10.026 EisenhauerEA TherasseP BogaertsJ SchwartzLH SargentD FordR New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 2009 45 228 47 10.1016/j.ejca.2008.10.026 Open DOISearch in Google Scholar

18. Hamm B, Thoeni RF, Gould RG, Bernardino ME, Lüning M, Saini S, et al. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 1994; 190: 417–23. doi: 10.1148/radiology.190.2.8284392 HammB ThoeniRF GouldRG BernardinoME LüningM SainiS Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging Radiology 1994 190 417 23 10.1148/radiology.190.2.8284392 Open DOISearch in Google Scholar

19. Ishida K, Tamura A, Kato K, Uesugi N, Osakabe M, Eizuka M, et al. Correlation between CT morphologic appearance and histologic findings in colorectal liver metastasis after preoperative chemotherapy. Abdom Radiol (NY) 2018; 43: 2991–3000. doi: 10.1007/s00261-018-1588-y IshidaK TamuraA KatoK UesugiN OsakabeM EizukaM Correlation between CT morphologic appearance and histologic findings in colorectal liver metastasis after preoperative chemotherapy Abdom Radiol (NY) 2018 43 2991 3000 10.1007/s00261-018-1588-y Open DOISearch in Google Scholar

20. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622–35. doi: 10.2214/ajr.06.1403 KohDM CollinsDJ Diffusion-weighted MRI in the body: applications and challenges in oncology AJR Am J Roentgenol 2007 188 1622 35 10.2214/ajr.06.1403 Open DOISearch in Google Scholar

21. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and per-fusion in neurologic disorders. Radiology 1986; 161: 401–7. doi: 10.1148/radiology.161.2.3763909 Le BihanD BretonE LallemandD GrenierP CabanisE Laval-JeantetM MR imaging of intravoxel incoherent motions: application to diffusion and per-fusion in neurologic disorders Radiology 1986 161 401 7 10.1148/radiology.161.2.3763909 Open DOISearch in Google Scholar

22. Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008; 248: 894–900. doi: 10.1148/radiol.2483071407 CuiY ZhangXP SunYS TangL ShenL Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases Radiology 2008 248 894 900 10.1148/radiol.2483071407 Open DOISearch in Google Scholar

23. Eccles CL, Haider EA, Haider MA, Fung S, Lockwood G, Dawson LA. Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations. Acta Oncol 2009; 48: 1034–43. doi: 10.1080/02841860903099972 EcclesCL HaiderEA HaiderMA FungS LockwoodG DawsonLA Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations Acta Oncol 2009 48 1034 43 10.1080/02841860903099972 Open DOISearch in Google Scholar

24. Koh DM, Scurr E, Collins D, Kanber B, Norman A, Leach MO, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007; 188: 1001–8. doi: 10.2214/ajr.06.0601 KohDM ScurrE CollinsD KanberB NormanA LeachMO Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients AJR Am J Roentgenol 2007 188 1001 8 10.2214/ajr.06.0601 Open DOISearch in Google Scholar

25. Marugami N, Tanaka T, Kitano S, Hirohashi S, Nishiofuku H, Takahashi A, et al. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging. Cardiovasc Intervent Radiol 2009; 32: 638–46. doi: 10.1007/s00270-009-9532-8 MarugamiN TanakaT KitanoS HirohashiS NishiofukuH TakahashiA Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging Cardiovasc Intervent Radiol 2009 32 638 46 10.1007/s00270-009-9532-8 Open DOISearch in Google Scholar

26. Schraml C, Schwenzer NF, Clasen S, Rempp HJ, Martirosian P, Claussen CD, et al. Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial results. J Magn Reson Imaging 2009; 29: 1308–16. doi: 10.1002/jmri.21770 SchramlC SchwenzerNF ClasenS RemppHJ MartirosianP ClaussenCD Navigator respiratory-triggered diffusion-weighted imaging in the follow-up after hepatic radiofrequency ablation-initial results J Magn Reson Imaging 2009 29 1308 16 10.1002/jmri.21770 Open DOISearch in Google Scholar

27. Schmeel FC, Simon B, Luetkens JA, Traber F, Meyer C, Schmeel LC, et al. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization. J Cancer Res Clin Oncol 2017; 143: 1531–41. doi: 10.1007/s00432-017-2395-5 SchmeelFC SimonB LuetkensJA TraberF MeyerC SchmeelLC Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization J Cancer Res Clin Oncol 2017 143 1531 41 10.1007/s00432-017-2395-5 Open DOISearch in Google Scholar

28. Lahrsow M, Albrecht MH, Bickford MW, Vogl TJ. Predicting treatment response of colorectal cancer liver metastases to conventional lipiodol-based transarterial chemoembolization using diffusion-weighted MR imaging: value of pretreatment apparent diffusion coefficients (ADC) and ADC changes under therapy. Cardiovasc Intervent Radiol 2017; 40: 852–9. doi: 10.1007/s00270-017-1634-0 LahrsowM AlbrechtMH BickfordMW VoglTJ Predicting treatment response of colorectal cancer liver metastases to conventional lipiodol-based transarterial chemoembolization using diffusion-weighted MR imaging: value of pretreatment apparent diffusion coefficients (ADC) and ADC changes under therapy Cardiovasc Intervent Radiol 2017 40 852 9 10.1007/s00270-017-1634-0 Open DOISearch in Google Scholar

29. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344–9. doi: 10.1016/j.jclinepi.2007.11.008 von ElmE AltmanDG EggerM PocockSJ GøtzschePC VandenbrouckeJP The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies J Clin Epidemiol 2008 61 344 9 10.1016/j.jclinepi.2007.11.008 Open DOISearch in Google Scholar

30. Mohnike K, Wieners G, Schwartz F, Seidensticker M, Pech M, Ruehl R, et al. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. Int J Radiat Oncol Biol Phys 2010; 78: 172–9. doi: 10.1016/j.ijrobp.2009.07.1700 MohnikeK WienersG SchwartzF SeidenstickerM PechM RuehlR Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival Int J Radiat Oncol Biol Phys 2010 78 172 9 10.1016/j.ijrobp.2009.07.1700 Open DOISearch in Google Scholar

31. Ingenerf MK, Karim H, Fink N, Ilhan H, Ricke J, Treitl KM, et al. Apparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility study. Acta Radiol 2022; 63: 877–88. doi: 10.1177/02841851211024004 IngenerfMK KarimH FinkN IlhanH RickeJ TreitlKM Apparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility study Acta Radiol 2022 63 877 88 10.1177/02841851211024004 Open DOISearch in Google Scholar

32. Outwater E, Tomaszewski JE, Daly JM, Kressel HY. Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. Radiology 1991; 180: 327–32. doi: 10.1148/radiology.180.2.2068294 OutwaterE TomaszewskiJE DalyJM KresselHY Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance Radiology 1991 180 327 32 10.1148/radiology.180.2.2068294 Open DOISearch in Google Scholar

33. Curvo-Semedo L, Lambregts DM, Maas M, Beets GL, Caseiro-Alves F, Beets-Tan RG. Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging 2012; 35: 1365–71. doi: 10.1002/jmri.23589 Curvo-SemedoL LambregtsDM MaasM BeetsGL Caseiro-AlvesF Beets-TanRG Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness J Magn Reson Imaging 2012 35 1365 71 10.1002/jmri.23589 Open DOISearch in Google Scholar

34. Liu Z, Fan JM, He C, Li ZF, Xu YS, Li Z, et al. Utility of diffusion weighted imaging with the quantitative apparent diffusion coefficient in diagnosing residual or recurrent hepatocellular carcinoma after transarterial chemoembolization: a meta-analysis. Cancer Imaging 2020; 20: 3. doi: 10.1186/s40644-019-0282-9 LiuZ FanJM HeC LiZF XuYS LiZ Utility of diffusion weighted imaging with the quantitative apparent diffusion coefficient in diagnosing residual or recurrent hepatocellular carcinoma after transarterial chemoembolization: a meta-analysis Cancer Imaging 2020 20 3 10.1186/s40644-019-0282-9 Open DOISearch in Google Scholar